Trial Profile
Dalteparin [dalteparin sodium] in prevention of recurrence of severe obstetrical complications in women without thrombophilia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Apr 2009
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Pregnancy; Pregnancy complications
- Focus Therapeutic Use
- 19 May 2008 New trial record.